We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$135M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$54.5M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$24.8M
4
SMH icon
VanEck Semiconductor ETF
SMH
+$13.3M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$11.5M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$60M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$30.3M
3
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$20.3M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$17.2M
5
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHOE
2226
Shoe Station Group
SHOE
$425M
$38K ﹤0.01%
3,424
-13,382
-80% -$124K
SFST icon
2227
Southern First Bancshares
SFST
$604M
$38K ﹤0.01%
1,043
+1,041
+52,050% +$37.6K
SGMO
2228
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$38K ﹤0.01%
2,551
+346
+16% +$3.83K
VATE icon
2229
INNOVATE Corp
VATE
$101M
$38K ﹤0.01%
+733
New +$39.1K
HEP
2230
DELISTED
Holly Energy Partners, L.P.
HEP
$38K ﹤0.01%
1,135
-6
-0.5% -$200
AUD
2231
DELISTED
Audacy, Inc.
AUD
$38K ﹤0.01%
3,294
-8,498
-72% -$86.8K
CDR
2232
DELISTED
Cedar Realty Trust, Inc
CDR
$38K ﹤0.01%
+1,023
New +$34.7K
IMMU
2233
DELISTED
Immunomedics Inc
IMMU
$38K ﹤0.01%
2,723
+1,948
+251% +$19.4K
ONDK
2234
DELISTED
On Deck Capital, Inc.
ONDK
$38K ﹤0.01%
8,123
+7,923
+3,962% +$36.7K
OPB
2235
DELISTED
Opus Bank Common Stock
OPB
$38K ﹤0.01%
1,603
+942
+143% +$21.8K
ZAYO
2236
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$38K ﹤0.01%
+1,100
New +$36.5K
BHVN
2237
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38K ﹤0.01%
1,010
-9,991
-91% -$303K
AXTI icon
2238
AXT Inc
AXTI
$4.92B
$37K ﹤0.01%
+4,001
New +$31.3K
CINF icon
2239
Cincinnati Financial
CINF
$27.5B
$37K ﹤0.01%
481
+281
+141% +$21.4K
CMI icon
2240
Cummins
CMI
$88.7B
$37K ﹤0.01%
224
-121
-35% -$19.6K
CRVS icon
2241
Corvus Pharmaceuticals
CRVS
$1.17B
$37K ﹤0.01%
2,267
-4,304
-65% -$59.5K
CVNA icon
2242
Carvana
CVNA
$75.1B
$37K ﹤0.01%
+12,750
New +$46.5K
EFAV icon
2243
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
$37K ﹤0.01%
523
+319
+156% +$22.5K
HCKT icon
2244
Hackett Group
HCKT
$277M
$37K ﹤0.01%
2,490
-11
-0.4% -$164
HRB icon
2245
H&R Block
HRB
$5.82B
$37K ﹤0.01%
1,403
+935
+200% +$27.2K
LLY icon
2246
Eli Lilly
LLY
$1.06T
$37K ﹤0.01%
436
+263
+152% +$21.6K
ORC
2247
Orchid Island Capital
ORC
$1.28B
$37K ﹤0.01%
+733
New +$36K
PNFP icon
2248
Pinnacle Financial Partners Inc
PNFP
$16.1B
$37K ﹤0.01%
548
+475
+651% +$29.9K
RNAC icon
2249
Cartesian Therapeutics
RNAC
$265M
$37K ﹤0.01%
69
-14
-17% -$7.45K
WFC icon
2250
Wells Fargo
WFC
$265B
$37K ﹤0.01%
677
-14,078
-95% -$748K
88 89
90
91 92

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.